Abstract
Speculation that schizophrenia is associated with abnormal brain development, the so-called neurodevelopmental hypothesis, has become so popular that it is rarely challenged in the literature. This paper critically examines the evidence for this hypothesis, taking primarily the “devil's advocate” position. The evidence from neuroimaging studies, from studies of prenatal and perinatal intrauterine events and of premorbid development are circumstantial with respect to brain development, many studies are methodologically flawed, and most do not exclude alternative explanations. Evidence from postmortem studies of anomalous cytoarchitecture in limbic and prefrontal cortices is especially noteworthy, as a developmental defect is virtually certain if artifacts can be excluded. Unfortunately, the studies responsible for these findings have serious methodological limitations. The neurobiological plausibility of the hypothesis, which might have been predicted to be its weakest aspect, has proved surprisingly unshakeable in a recent series of animal studies. Ironically, the principal weakness of the neurodevelopmental hypothesis at present is the clinical database on which it rests.
Article PDF
Author information
Authors and Affiliations
Additional information
This paper was presented at the integrated symposium “A New Understanding: Neurological Basis and Long-Term Outcome of Schizophrenia” chaired by Herbert Y. Meltzer and Leif H. Lindström at the CINP Congress, June 28, 1994, in Washington, DC
Rights and permissions
About this article
Cite this article
Weinberger, D. On the Plausibility of “The Neurodevelopmental Hypothesis” of Schizophrenia. Neuropsychopharmacol 14 (Suppl 1), 1–11 (1996). https://doi.org/10.1016/0893-133X(95)00199-N
Published:
Issue Date:
DOI: https://doi.org/10.1016/0893-133X(95)00199-N
Keywords
This article is cited by
-
Finding new and better treatments for psychiatric disorders
Neuropsychopharmacology (2024)
-
Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors
Journal of Neural Transmission (2023)
-
Maternal Immune Activation Induces Cortical Catecholaminergic Hypofunction and Cognitive Impairments in Offspring
Journal of Neuroimmune Pharmacology (2023)
-
Schizophrenia, Curcumin and Minimizing Side Effects of Antipsychotic Drugs: Possible Mechanisms
Neurochemical Research (2023)
-
Elevation of EGR1/zif268, a Neural Activity Marker, in the Auditory Cortex of Patients with Schizophrenia and its Animal Model
Neurochemical Research (2022)